EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic

Rodrigue Kamga Wouambo iD, Cecile Ingrid Djuikoué iD, Livo Forgu Esemu iD, Luc Aime Kagoue Simeni iD, Murielle Chantale Tchitchoua, Paule Dana Djouela Djoulako iD, Joseph Fokam iD, Madeleine Singwe-Ngandeu, Eitel Mpoudi Ngolé, Teke Apalata iD

Viruses · 2023

DOI: 10.3390/v15020407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Rodrigue Kamga Wouambo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hepatology, Department of Medicine II, University of Leipzig Medical Centre, 04103 Leipzig, Germany. Hauptthemen laut MEDLINE: Pandemics, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID-19 remains a rapidly evolving and deadly pandemic worldwide. This necessitates the continuous assessment of existing diagnostic tools for a robust, up-to-date, and cost-effective pandemic response strategy. We sought to determine the infection rate (PCR-positivity) and degree of spread (IgM/IgG) of SARS-CoV-2 in three university settings in Cameroon Method: Study volunteers were recruited from November 2020 to July 2021 among COVID-19 non-vaccinated students in three Universities from two regions of Cameroon (West and Centre). Molecular testing was performed by RT-qPCR on nasopharyngeal swabs, and IgM/IgG antibodies in plasma were detected using the Abbott Panbio IgM/IgG rapid diagnostic test (RDT) at the Virology Laboratory of CREMER/IMPM/MINRESI. The molecular and serological profiles were compared, and p < 0.05 was considered statistically significant.

Results

Amongst the 291 participants enrolled (mean age 22.59 ± 10.43 years), 19.59% (57/291) were symptomatic and 80.41% (234/291) were asymptomatic. The overall COVID-19 PCR-positivity rate was 21.31% (62/291), distributed as follows: 25.25% from UdM-Bangangte, 27.27% from ISSBA-Yaounde, and 5% from IUEs/INSAM-Yaounde. Women were more affected than men (28.76% [44/153] vs. 13.04% [18/138], p < 0.0007), and had higher seropositivity rates to IgM+/IgG+ (15.69% [24/153] vs. 7.25% [10/138], p < 0.01). Participants from Bangangté, the nomadic, and the “non-contact cases” primarily presented an active infection compared to those from Yaoundé (p= 0.05, p = 0.05, and p = 0.01, respectively). Overall IgG seropositivity (IgM−/IgG+ and IgM+/IgG+) was 24.4% (71/291). A proportion of 26.92% (7/26) presenting COVID-19 IgM+/IgG− had negative PCR vs. 73.08% (19/26) with positive PCR, p < 0.0001. Furthermore, 17.65% (6/34) with COVID-19 IgM+/IgG+ had a negative PCR as compared to 82.35% with a positive PCR (28/34), p < 0.0001. Lastly, 7.22% (14/194) with IgM−/IgG− had a positive PCR.

Conclusion

This study calls for a rapid preparedness and response strategy in higher institutes in the case of any future pathogen with pandemic or epidemic potential. The observed disparity between IgG/IgM and the viral profile supports prioritizing assays targeting the virus (nucleic acid or antigen) for diagnosis and antibody screening for sero-surveys.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PandemicsCOVID-19MaleFemaleHumansChildAdolescentYoung AdultAdultReverse Transcriptase Polymerase Chain ReactionUniversitiesCameroonSARS-CoV-2Molecular Diagnostic TechniquesImmunoglobulin MImmunoglobulin GCOVID-19 Testing

Stichwörter der Autor:innen

COVID-19Cameroonprevalenceprivate universitiesserological markers (IgM/IgG)

Substanzen

Immunoglobulin MImmunoglobulin G

Autor:innen und Institutionen

  • Section of Hepatology, Department of Medicine II, University of Leipzig Medical Centre, 04103 Leipzig, Germany.
  • American Society for Microbiology (ASM), ASM Cameroon, Bangangte, Cameroon.
  • Faculty of Health Science, Université des Montagnes, Bangangte, Cameroon.
  • Laboratory of Fundamental Virology, Centre for Research on Emerging and Reemerging Diseases (CREMER), Yaounde, Cameroon.
  • Department of Biomedical Sciences, Faculty of Health Science, University of Buea, Buea, Cameroon.
  • Department of Microbiology, Faculty of Health Science, University of Buea, Buea, Cameroon.

ORCID-Profile: Rodrigue Kamga Wouambo, Cecile Ingrid Djuikoué, Livo Forgu Esemu, Luc Aime Kagoue Simeni, Paule Dana Djouela Djoulako, Joseph Fokam, Teke Apalata

Zitieren

APA

Kamga Wouambo, R., Djuikoué, C. I., Esemu, L. F., Kagoue Simeni, L. A., Tchitchoua, M. C., Djouela Djoulako, P. D., Fokam, J., Singwe-Ngandeu, M., Mpoudi Ngolé, E., & Apalata, T. (2023). Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic. Viruses. https://doi.org/10.3390/v15020407

Vancouver

Kamga Wouambo R, Djuikoué CI, Esemu LF, Kagoue Simeni LA, Tchitchoua MC, Djouela Djoulako PD, et al. Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic. Viruses. 2023. doi:10.3390/v15020407

BibTeX
@article{KamgaWouambo2023,
  author = {Kamga Wouambo, Rodrigue and Djuikoué, Cecile Ingrid and Esemu, Livo Forgu and Kagoue Simeni, Luc Aime and Tchitchoua, Murielle Chantale and Djouela Djoulako, Paule Dana and Fokam, Joseph and Singwe-Ngandeu, Madeleine and Mpoudi Ngolé, Eitel and Apalata, Teke},
  title = {Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15020407}
}
Kostenlos starten →